Agency Forms Undergoing Paperwork Reduction Act Review, 38065-38066 [2012-15574]
Download as PDF
<![CDATA[
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
information collection documents from
the General Services Administration,
Regulatory Secretariat (MVCB), 1275
First Street NE., Washington, DC 20417,
telephone (202) 501–4755. Please cite
OMB Control No. 3090–0044, GSA Form
3453, Application/Permit for Use of
Space in Public Buildings and Grounds,
in all correspondence.
Dated: June 13, 2012.
Casey Coleman,
Chief Information Officer.
[FR Doc. 2012–15480 Filed 6–25–12; 8:45 am]
BILLING CODE 6820–34–P
GENERAL SERVICES
ADMINISTRATION
[Notice–MK–2012–01; Docket No. 2012–
0002; Sequence 14]
The President’s Management Advisory
Board (PMAB); Notification of
Upcoming Public Advisory Meeting
Office of Executive Councils,
U.S. General Services Administration
(GSA).
ACTION: Meeting notice.
AGENCY:
The President’s Management
Advisory Board (PMAB), a Federal
Advisory Committee established in
accordance with the Federal Advisory
Committee Act (FACA), 5 U.S.C., App.,
and Executive Order 13538, will hold a
public meeting on Wednesday, July 11,
2012.
DATES: Effective date: June 26, 2012.
Meeting date: The meeting will be
held on Wednesday, July 11, 2012,
beginning at 9 a.m. eastern time, ending
no later than 3 p.m.
FOR FURTHER INFORMATION CONTACT: Mr.
Scott Winslow, Designated Federal
Officer, President’s Management
Advisory Board, Office of Executive
Councils, General Services
Administration, 1776 G Street NW.,
Washington, DC 20006, at
scott.winslow@gsa.gov.
SUPPLEMENTARY INFORMATION:
Background: The PMAB was
established to provide independent
advice and recommendations to the
President and the President’s
Management Council on a wide range of
issues related to the development of
effective strategies for the
implementation of best business
practices to improve Federal
Government management and
operation, with a particular focus on
productivity and the application of
technology.
Agenda: The main purpose for this
meeting is for the PMAB to discuss their
work on the following: Improving
rmajette on DSK2TPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
Strategic Sourcing and Curbing
Improper Payments. Additionally,
PMAB will hear reports from federal
agency executives regarding their
progress implementing last year’s
recommendations to the President’s
Management Council. Those
recommendations were aimed at
improving Information Technology (IT)
portfolio and project management, IT
vendor performance management,
Senior Executive Service (SES)
leadership development and SES
performance appraisal systems. More
detailed information on the PMAB
recommendations can be found on the
PMAB Web site (see below).
Meeting Access: The PMAB will
convene its meeting in the Eisenhower
Executive Office Building, 1650
Pennsylvania Avenue NW., Washington,
DC. Due to security, there will be no
public admittance to the Eisenhower
Building to attend the meeting.
However, the meeting is open to the
public; interested members of the public
may view the PMAB’s discussion at
https://www.whitehouse.gov/live.
Members of the public wishing to
comment on the discussion or topics
outlined in the Agenda should follow
the steps detailed in Procedures for
Providing Public Comments below.
Availability of Materials for the
Meeting: Please see the PMAB Web site
(https://www.whitehouse.gov/
administration/advisory-boards/pmab)
for any available materials and detailed
meeting minutes after the meeting.
Procedures for Providing Public
Comments: In general, public statements
will be posted on the PMAB Web site
(see above). Non-electronic documents
will be made available for public
inspection and copying in PMAB offices
at GSA, 1776 G Street NW., Washington,
DC 20006, on official business days
between the hours of 10 a.m. and 5 p.m.
eastern time. You can make an
appointment to inspect statements by
telephoning (202) 501–1398. All
statements, including attachments and
other supporting materials, received are
part of the public record and subject to
public disclosure. Any statements
submitted in connection with the PMAB
meeting will be made available to the
public under the provisions of the
Federal Advisory Committee Act.
The public is invited to submit
written statements for this meeting to
the PMAB prior to the meeting until 5
p.m. eastern time on Tuesday, July 10,
2012, by either of the following
methods:
Electronic or Paper Statements:
Submit written statements to Mr.
Winslow, Designated Federal Officer at
scott.winslow@gsa.gov; or send paper
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
38065
statements in triplicate to Mr. Winslow
at the PMAB GSA address above.
Dated: June 20, 2012.
John C. Thomas,
Deputy Director, Office of Committee and
Regulatory Management, General Services
Administration.
[FR Doc. 2012–15527 Filed 6–25–12; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30-Day–12–12ET]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call (404) 639–7570 or send an
email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC 20503 or by fax to (202) 395–5806.
Written comments should be received
within 30 days of this notice.
Proposed Project
Communications Research for the
Development of Messages and Materials
about Cytomegalovirus (CMV)—NEW—
Prevention Research Branch, National
Center on Birth Defects and
Developmental Disabilities (NCBDDD),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cytomegalovirus (CMV) is the most
common congenital infection in the
U.S., causing disabilities in more than
5,500 children born each year (CDC,
2010). Disabilities related to congenital
CMV are more common than other wellknown childhood conditions, such as
Down syndrome, fetal alcohol
syndrome, and neural tube defects, and
can include hearing or vision loss,
mental retardation, psychomotor delays,
and speech and language impairment.
This is a multiphase communication
research study that will help inform
CDC’s development of materials and
prevention messaging about congenital
CMV. The information collection
activities will consist of two phases of
research: Phase I will consist of focus
groups and Phase II will consist of a
web survey. First, we plan to conduct 8
E:\FR\FM\26JNN1.SGM
26JNN1
38066
Federal Register / Vol. 77, No. 123 / Tuesday, June 26, 2012 / Notices
focus groups with 9 respondents each to
identify potential messaging frames for
communicating information about
congenital CMV to the target audiences
and adopting CMV preventive
guidelines. We will also conduct some
preliminary testing of existing CDC
CMV draft materials (factsheet and
video). We estimate that we will screen
144 women in order to recruit 72
participants for the focus groups. These
focus groups will be conducted in
Atlanta, Georgia (4) and San Diego,
California (4). Findings from the Phase
I focus groups will inform refinements
their attitudes, beliefs, and behavioral
intentions regarding prevention
behaviors and (4) assess knowledge,
attitudes and behaviors pre- and postinterventions with a larger target
audience sample (N=800). We estimate
that we will screen 4,800 women in
order to recruit 800 respondents for the
online survey.
This request is submitted to obtain
OMB clearance for two years. There are
no costs to the respondents other than
their time.
to existing CDC messages and materials
(factsheet and video), which will be
further tested in the second information
collection activity, the web survey.
Phase II research will include an online
survey to test the refined
communication interventions (factsheet
and video). This web survey will: (1)
Examine baseline awareness and
knowledge regarding CMV, (2) assess
baseline CMV prevention behaviors
prior to viewing CMV communication
interventions (factsheet and video), (3)
assess appeal and evaluate the impact of
CMV communication interventions on
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Number of
respondents
Form name
Number of responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Phase I: Focus Groups
Women of childbearing age ..................................
Participant screener .....
Demographic questionnaire.
Informed consent form
Focus group .................
144
72
1
1
5/60
15/60
12
18
72
72
1
1
15/60
90/60
18
108
4,800
800
1
1
3/60
11/60
240
147
Phase II: Web Survey
Women of childbearing age ..................................
Dated: June 18, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI),
Office of the Associate Director for Science
(OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012–15574 Filed 6–25–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[CMS–5505–N3]
Medicare Program; Announcement of a
New Opportunity for Participation in
the Advance Payment Model for
Accountable Care Organizations
(ACOs)
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
rmajette on DSK2TPTVN1PROD with NOTICES
AGENCY:
This notice announces a new
opportunity for participation in the
Advance Payment Model for certain
accountable care organizations
participating in the Medicare Shared
Savings Program scheduled to begin in
January 2013.
VerDate Mar<15>2010
15:33 Jun 25, 2012
Jkt 226001
Application Submission
Deadline for the Advance Payment
Model: Applications for the
performance period beginning on
January 1, 2013 will be accepted from
August 1, 2012 through September 19,
2012.
FOR FURTHER INFORMATION CONTACT:
Maria Alexander, (410) 786–4792.
SUPPLEMENTARY INFORMATION:
DATES:
I. Background
Centers for Medicare & Medicaid
Services
SUMMARY:
Participant per screener
Web Survey ..................
The Centers for Medicare & Medicaid
Services (CMS) is committed to
achieving better health for populations,
better health care for individuals, and
lower growth in expenditures through
continuous improvement for Medicare,
Medicaid, and Children’s Health
Insurance Program beneficiaries. One
potential mechanism for achieving these
goals is for CMS to partner with groups
of health care providers of services and
suppliers that have a mechanism for
shared governance and have formed an
Accountable Care Organization (ACO)
through which they work together to
coordinate care for a specified group of
patients. We will pursue such
partnerships through complementary
efforts, including the Medicare Shared
Savings Program and initiatives
undertaken by the Center for Medicare
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
and Medicaid Innovation (Innovation
Center).
The Advance Payment Model is an
Innovation Center initiative designed for
participants in the Medicare Shared
Savings Program in need of prepayment
of expected shared savings to build their
capacity to provide high quality,
coordinated care and generate cost
savings. The Advance Payment Model
will test whether and how prepaying a
portion of future shared savings could
increase participation in the Medicare
Shared Savings Program, and whether
advance payments will enhance the
ability of ACOs to effectively coordinate
care and generate Medicare savings, as
well as the speed at which they attain
that goal.
In the November 2, 2011 Federal
Register (76 FR 68012), we published a
notice entitled ‘‘Medicare Program;
Advance Payment Model’’ that
announced the testing of the Advance
Payment Model for certain ACOs
participating in the Medicare Shared
Savings Program scheduled to begin in
2012 and provided information about
the Advance Payment Model and the
application process. In November 30,
2011 Federal Register (76 FR 74067), we
published a second notice that extended
the application deadline for the first
E:\FR\FM\26JNN1.SGM
26JNN1
]]>Agencies
[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38065-38066]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-15574]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30-Day-12-12ET]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
(404) 639-7570 or send an email to omb@cdc.gov. Send written comments
to CDC Desk Officer, Office of Management and Budget, Washington, DC
20503 or by fax to (202) 395-5806. Written comments should be received
within 30 days of this notice.
Proposed Project
Communications Research for the Development of Messages and
Materials about Cytomegalovirus (CMV)--NEW--Prevention Research Branch,
National Center on Birth Defects and Developmental Disabilities
(NCBDDD), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Cytomegalovirus (CMV) is the most common congenital infection in
the U.S., causing disabilities in more than 5,500 children born each
year (CDC, 2010). Disabilities related to congenital CMV are more
common than other well-known childhood conditions, such as Down
syndrome, fetal alcohol syndrome, and neural tube defects, and can
include hearing or vision loss, mental retardation, psychomotor delays,
and speech and language impairment.
This is a multiphase communication research study that will help
inform CDC's development of materials and prevention messaging about
congenital CMV. The information collection activities will consist of
two phases of research: Phase I will consist of focus groups and Phase
II will consist of a web survey. First, we plan to conduct 8
[[Page 38066]]
focus groups with 9 respondents each to identify potential messaging
frames for communicating information about congenital CMV to the target
audiences and adopting CMV preventive guidelines. We will also conduct
some preliminary testing of existing CDC CMV draft materials (factsheet
and video). We estimate that we will screen 144 women in order to
recruit 72 participants for the focus groups. These focus groups will
be conducted in Atlanta, Georgia (4) and San Diego, California (4).
Findings from the Phase I focus groups will inform refinements to
existing CDC messages and materials (factsheet and video), which will
be further tested in the second information collection activity, the
web survey. Phase II research will include an online survey to test the
refined communication interventions (factsheet and video). This web
survey will: (1) Examine baseline awareness and knowledge regarding
CMV, (2) assess baseline CMV prevention behaviors prior to viewing CMV
communication interventions (factsheet and video), (3) assess appeal
and evaluate the impact of CMV communication interventions on their
attitudes, beliefs, and behavioral intentions regarding prevention
behaviors and (4) assess knowledge, attitudes and behaviors pre- and
post- interventions with a larger target audience sample (N=800). We
estimate that we will screen 4,800 women in order to recruit 800
respondents for the online survey.
This request is submitted to obtain OMB clearance for two years.
There are no costs to the respondents other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total burden
Type of respondent Form name respondents responses per response (in hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Phase I: Focus Groups
----------------------------------------------------------------------------------------------------------------
Women of childbearing age..... Participant 144 1 5/60 12
screener.
Demographic 72 1 15/60 18
questionnaire.
Informed consent 72 1 15/60 18
form.
Focus group..... 72 1 90/60 108
----------------------------------------------------------------------------------------------------------------
Phase II: Web Survey
----------------------------------------------------------------------------------------------------------------
Women of childbearing age..... Participant per 4,800 1 3/60 240
screener.
Web Survey...... 800 1 11/60 147
----------------------------------------------------------------------------------------------------------------
Dated: June 18, 2012.
Ron A. Otten,
Director, Office of Scientific Integrity (OSI), Office of the Associate
Director for Science (OADS), Office of the Director, Centers for
Disease Control and Prevention.
[FR Doc. 2012-15574 Filed 6-25-12; 8:45 am]
BILLING CODE 4163-18-P
